二期翻修再植入时培养阳性是否增加假体周围感染再感染风险
该回顾性研究纳入2012至2016年按二期翻修方案治疗的204例假体周围感染患者(111膝、93髋),中位随访42个月。再植入时25%(51/204)患者至少一次培养阳性,培养阳性者再感染风险升高(HR 2.27,95%CI 1.181-4.363,P=.014),单一培养阳性亦升高(HR 2.421,95%CI 1.139-5.143,P=.021)。
要点
- 再植入时培养阳性常见,占25%(51/204),其中19.1%(39/204)仅为单一培养阳性。
- 再植入培养阳性者再感染风险升高(HR 2.27,95%CI 1.181-4.363,P=.014)。
- 再植入单一培养阳性不应视为污染,可考虑延长再植入后抗生素疗程。
核心结论
- 再植入时培养阳性较常见且无论数量多少均增加再感染风险,单一阳性培养不应视为污染,可考虑延长再植入后抗生素治疗。
研究设计与样本
- 回顾性研究,纳入2012至2016年按二期翻修方案治疗的204例假体周围感染患者(111膝、93髋),中位随访42个月,PJI按2011年MSIS标准诊断。
主要发现
- 再植入时25%(51/204)患者至少一次培养阳性,19.1%(39/204)仅为单一培养阳性。
- 培养阴性感染患者再植入培养阳性风险更高(HR 2.946,95%CI 1.247-6.961,P=.014)。
- 感染全髋关节置换患者再植入培养阳性风险更高(HR 3.547,95%CI 1.7-7.4,P=.001)。
- 再植入培养阳性者再感染风险更高(HR 2.27,95%CI 1.181-4.363,P=.014),单一培养阳性者亦然(HR 2.421,95%CI 1.139-5.143,P=.021)。
关键数值与推荐
- PJI诊断采用2011年MSIS标准。
- 主要终点为因感染再次翻修。
- 再植入培养阳性率25%(51/204),单一培养阳性率19.1%(39/204)。
临床怎么用
- 再植入术中培养阳性结果应重视,单一阳性不应默认污染。
- 对再植入培养阳性者,可考虑延长再植入后抗生素疗程。
- 培养阴性感染与感染THA患者再植入培养阳性风险较高,应加强关注。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intraoperative cultures are important in the diagnosis and targeted treatment of periprosthetic joint infection (PJI). Positive cultures at reimplantation during a two-stage exchange are discussed as a risk factor for reinfection. The aim of this study is the investigation of the incidence and risk factors for positive cultures during reimplantation. METHODS: We retrospectively identified 204 patients (111 knees, 93 hips) who were treated between 2012 and 2016 for PJI using a two-stage exchange protocol at a median follow-up of 42 months. PJI was diagnosed using the criteria of the musculoskeletal infection society (MSIS) of 2011. All cultural findings from first and second stage surgery were recorded. The primary endpoint was revision for infection. Risk factors for positive cultures and reinfection were analyzed. RESULTS: During reimplantation 25% (51/204) of patients had at least one positive culture, in 19.1% (39/204) only a single culture. Patients with culture-negative infections had a higher risk for positive cultures at reimplantation (HR 2.946 (95% CI 1.247-6.961), P = .014) and patients with infected total hip arthroplasty (THA) (HR 3.547 (95% CI 1.7-7.4), P = .001). Patients with positive cultures during reimplantation had a higher risk for reinfection (HR 2.27 (95% CI 1.181-4.363), P = .014) as well as patients with a single positive culture (HR 2.421 (95% CI 1.139-5.143), P = .021). CONCLUSION: As positive cultures are common and increase reinfection risk irrespective of their numbers, longer antibiotic therapy following reimplantation can be an option. Single positive cultures in reimplantation surgery should not be considered contamination.
引用
- Theil C, Freudenberg SC, Gosheger G, et al. Do Positive Cultures at Second Stage Re-Implantation Increase the Risk for Reinfection in Two-Stage Exchange for Periprosthetic Joint Infection? J Arthroplasty. 2020. PMID: 32546394. doi:10.1016/j.arth.2020.05.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。